DIRECTV (NASDAQ:DTV) today announced that third quarter 2014 revenues
increased 6% to $8.37 billion, adjusted operating profit before
depreciation and amortization 1 (OPBDA) and adjusted operating
profit both increased 5% to $2.04 billion and $1.28 billion,
respectively, and adjusted diluted earnings per share increased 4% to
$1.33 compared to last year's third quarter.
The company's brand dedicated to the design, manufacture and marketing of a broad range of buses and coaches makes its debut on the Brazilian market at FetransRio 2014, one of the country's largest trade fairs dedicated to the public transport sector.
Sunoco Logistics Partners L.P. (NYSE: SXL) today announced a successful
open season for Sunoco Pipeline L.P.’s Mariner East 2 project, the
second phase of the Company’s broader plan to provide critical pipeline
transportation from the Marcellus and Utica Shales.
Epizyme, Inc., a clinical stage biopharmaceutical company creating
innovative personalized therapeutics for patients with genetically
defined cancers, today announced the publication on the website of the
American Society of Hematology (ASH) of an abstract entitled “The DOT1L
Inhibitor EPZ-5676: Safety and Activity in Relapsed/Refractory Patients
with MLL-Rearranged Leukemia”. The abstract contains preliminary data
from the Phase 1 trial of EPZ-5676, a potent and selective inhibitor of
the DOT1L histone methyltransferase (HMT). EPZ-5676 is being developed
for the treatment of acute leukemia with alterations in the MLL
gene (MLL-r) or partial tandem duplications within MLL (MLL-PTD).
The Company plans to present updated data from the trial at the 56 th
annual meeting of ASH in San Francisco, Calif.
Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company
creating innovative personalized therapeutics for patients with
genetically defined cancers, today announced third quarter 2014
operating and financial results and confirmed 2014 guidance.
New Source Energy Partners L.P., a Delaware limited partnership
(NYSE:NSLP) (the “Partnership” or “New Source”), today announced
financial and operating results for the quarter ended September 30, 2014
and updates guidance for the fourth quarter 2014 and full year 2015.
J. Braxton Carter, Executive Vice President and Chief Financial Officer
of T-Mobile US, Inc. (NYSE:TMUS), will speak at 8:45 a.m. Eastern
Standard Time on Thursday, November 13 th at the Wells Fargo
Technology, Media & Telecom Conference in New York, NY.
Global education leader Houghton Mifflin Harcourt Company (“HMH” or “the
Company”) (NASDAQ: HMHC) today announced its financial results for the
third quarter ended September 30, 2014 as well as an updated outlook for
the full year 2014.
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine
platform company developing targeted and programmable therapeutics
called Accurins TM , today announced a joint research and
development agreement with Merck, known as MSD outside the United States
and Canada, through a subsidiary, to discover and develop novel
nanomedicines for oncology.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.